Literature DB >> 3856904

Menstrual-PGF2 alpha, PGE2 and TXA2 in normal and dysmenorrheic women and their temporal relationship to dysmenorrhea.

A M Powell, W Y Chan, P Alvin, I F Litt.   

Abstract

Although it has been demonstrated that primary dysmenorrhea is associated with elevated levels of PGF2 alpha in the menstrual fluid, little is actually known of the menstrual-PG profiles of either dysmenorrheic or normal women. In this study, menstrual fluid from normal and dysmenorrheic women was collected from tampons and extracted for PG-like substances. The PGF2 alpha, PGE2 and TXA2 content was analyzed by RIA. This study demonstrates that dysmenorrheics have significantly higher levels/concentrations of menstrual-PGF2 alpha and PGE2 than do normal women, and that there is no difference in the menstrual-PGF2 alpha : PGE2 ratio between the two groups. Also, there is no significant difference in the amount/concentration of menstrual-thromboxane between dysmenorrheic and normal women. Of the parameters considered, the levels/-concentrations of menstrual-PGF2 alpha, PGE2 and TXA2, dysmenorrheic pain correlates best with the rate of menstrual-PGF2 alpha release.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3856904     DOI: 10.1016/0090-6980(85)90208-4

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  9 in total

1.  Menstrual pain and epithelial ovarian cancer risk.

Authors:  Ana Babic; Daniel W Cramer; Linda J Titus; Shelley S Tworoger; Kathryn L Terry
Journal:  Cancer Causes Control       Date:  2014-09-05       Impact factor: 2.506

2.  Morinda citrifolia (Noni) as an Anti-Inflammatory Treatment in Women with Primary Dysmenorrhoea: A Randomised Double-Blind Placebo-Controlled Trial.

Authors:  H M Fletcher; J Dawkins; C Rattray; G Wharfe; M Reid; G Gordon-Strachan
Journal:  Obstet Gynecol Int       Date:  2013-01-29

3.  Animal study on primary dysmenorrhoea treatment at different administration times.

Authors:  Bao-Chan Pu; Ling Fang; Li-Na Gao; Rui Liu; Ai-Zhu Li
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-02       Impact factor: 2.629

Review 4.  A review of in vitro and in vivo studies on the efficacy of herbal medicines for primary dysmenorrhea.

Authors:  Kyoung-Sun Park; Kang-In Park; Deok-Sang Hwang; Jin-Moo Lee; Jun-Bock Jang; Chang-Hoon Lee
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-05       Impact factor: 2.629

5.  Abnormal reward system network in primary dysmenorrhea.

Authors:  Qi Zhang; Siyi Yu; Yanan Wang; Minyu Wang; Ya Yang; Wei Wei; Xiaoli Guo; Fang Zeng; Fanrong Liang; Jie Yang
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

6.  Analysis of recurrence factors associated with conservative surgery for ovarian-type endometriosis.

Authors:  Gu Huang; Xiang Fan; Pengfeng Zhu
Journal:  Ann Transl Med       Date:  2022-03

7.  Regulation of Mild Moxibustion on Uterine Vascular and Prostaglandin Contents in Primary Dysmenorrhea Rat Model.

Authors:  Xuemei Li; Sha Guo; Zhaoheng Chen; Kuiyu Ren; Hong Zhang; Shuguang Yu; Sha Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-10       Impact factor: 2.629

8.  Effect of jingqian zhitong fang on serum sex hormone levels in women with primary dysmenorrhea.

Authors:  Na Dai; Ling Fang; Yu-Bo Li; Yu-Ming Wang; Ju Yin; Bao-Chan Pu
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-16       Impact factor: 2.629

9.  Local Usage of Nigella sativa Oil as an Innovative Method to Attenuate Primary Dysmenorrhea: A Randomized Double-blind Clinical Trial.

Authors:  Ezat Samadipour; Mohammad Hassan Rakhshani; Akram Kooshki; Bahareh Amin
Journal:  Oman Med J       Date:  2020-09-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.